Cargando...
Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic()
Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing ra...
Guardado en:
| Publicado en: | Radiother Oncol |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7255703/ https://ncbi.nlm.nih.gov/pubmed/32474128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2020.05.032 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|